Anti-lilrb1 antibody and its uses

CL202600876A1Pending Publication Date: 2026-07-10LG CHEM LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CL202600876
Authority / Receiving Office: CL · CL
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2020-12-22
Filing Date: 2026-03-24
Publication Date: 2026-07-10

Application Information

Patent Timeline

22 Dec 2020

Priority

24 Mar 2026

Application

CL202600876

10 Jul 2026

Publication

CL202600876A1

IPC: A61P35/00; A61K39/00; C07K16/28

CPC: C07K16/2803; A61P35/00; C07K2317/565; C07K2317/56; C07K2317/76; C07K2317/92; C07K2317/73; C07K2317/33

Inventors: CHOI Yoon Aa; KIM Jung A

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to an anti-LILRB1 antibody having increased specificity for LILRB1, and to uses thereof. Specifically, an anti-LILRB1 antibody or antigen-binding fragment thereof, and its uses in cancer treatment, are provided.

Need to check novelty before this filing date? Find Prior Art